Annual report pursuant to Section 13 and 15(d)

Equity Transactions (Tables)

v3.20.1
Equity Transactions (Tables)
 12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of Stock Options, Valuation Assumptions
The fair values of stock options issued were determined on the grant date using the Black-Scholes option pricing model and the following weighted assumptions for the years ended December 31, 2019 and 2018:
 
2019
 
2018
Common stock price on grant date
$
0.65

 
$
2.69

Expected life (in years)
4.75

 
4.75

Risk-free interest rate
1.75
%
 
2.76
%
Expected stock volatility
82
%
 
64
%
Expected dividend yield
0
%
 
0
%
Fair value of stock options granted
$
0.42

 
$
1.47

Schedule of Share-based Compensation, Stock Options, Activity
Stock option activity for the year ended December 31, 2019 is as follows:
 
Shares
(in thousands)
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (in years)
 
Aggregate Intrinsic Value
(in thousands)
Balance unexercised at January 1, 2019
211

 
$
168.25

 
3.34
 
$
—

Granted
55

 
$
16.25

 

 


Exercised
—

 
$
—

 

 

Forfeited
(94
)
 
$
183.50

 

 

Balance unexercised at December 31, 2019
172

 
$
111.25

 
4.18
 
$
—

Exercisable at December 31, 2019
95

 
$
174.00

 
2.32
 
$
—

Vested and expected to vest after December 31, 2019
172

 
$
111.25

 
4.18
 
$
—

Schedule of Share-based Compensation, Stock Options, by Exercise Price Range
The following is a summary of the Company’s stock options outstanding at December 31, 2019:
Range of Exercise Price
Number Outstanding
(in thousands)
 
Weighted Average Remaining Contractual Term (in years)
 
Weighted Average Exercise Price
 
Number Exercisable
(in thousands)
 
Weighted Average Exercise Price
$338.50 - $338.50
4

 
0.42
 
$
338.50

 
4

 
$
338.50

$328.75 - $328.75
8

 
0.21
 
$
328.75

 
8

 
$
328.75

$326.75 - $326.75
—

 
0.32
 
$
326.75

 
—

 
$
326.75

$312.75 - $312.75
9

 
0.59
 
$
312.75

 
9

 
$
312.75

$200.75 - $231.25
6

 
1.37
 
$
228.50

 
6

 
$
229.00

$73.00 - $155.50
61

 
2.58
 
$
132.25

 
52

 
$
139.00

$66.25 - $66.25
27

 
5.43
 
$
66.25

 
14

 
$
66.25

$62.50 - $62.50
2

 
4.95
 
$
62.50

 
1

 
$
62.50

$17.75 - $58.75
1

 
5.97
 
$
55.75

 
—

 
$
58.75

$16.25 - $16.25
55

 
7.06
 
$
16.25

 
—

 
$
—

 
173

 
4.17
 
$
111.25

 
95

 
$
174.00

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
RSU activity during the year ended December 31, 2019 was as follows:
 
Shares (in thousands)
 
Weighted Average Grant Date Fair Value
 
Aggregate Intrinsic Value (in thousands)
Balance nonvested at January 1, 2019
237

 
$
75.75

 
$
13,185

Granted
29

 
$
21.75

 
 
Vested
(57
)
 
$
84.75

 
 
Forfeited
(47
)
 
$
72.75

 
 
Balance nonvested at December 31, 2019
162

 
$
63.50

 
$
2,031

Vested and expected to vest at December 31, 2019
161

 
$
63.25

 
$
2,015

Schedule of Share-based Compensation Expense Allocation
Stock-based compensation expense related to all employee and, where applicable, non-employee stock-based awards was as follows for the years ended December 31, 2019 and 2018 (in thousands):
 
Year Ended December 31,
 
2019
 
2018
Consolidated Statement of Operations Classification:
 
 
 
Cost of sales
$
278

 
$
547

Sales and marketing
271

 
498

Product development
332

 
753

General and administrative
5,462

 
11,019

Total
$
6,343

 
$
12,817